DIABETIC PERIPHERAL NEUROPATHIC PAIN
Clinical trials for DIABETIC PERIPHERAL NEUROPATHIC PAIN explained in plain language.
Never miss a new study
Get alerted when new DIABETIC PERIPHERAL NEUROPATHIC PAIN trials appear
Sign up with your email to follow new studies for DIABETIC PERIPHERAL NEUROPATHIC PAIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for burning foot pain? drug trial seeks relief for diabetic nerve suffering
Symptom relief Recruiting nowThis study is testing an investigational drug, LY4065967, to see if it safely reduces the chronic pain caused by nerve damage from diabetes. About 150 adults with diabetic nerve pain in their feet and legs will receive either the new drug or a placebo for several weeks. Researche…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
New pill aims to tame diabetic nerve pain
Symptom relief Recruiting nowThis study is testing a new oral medication, VX-993, to see if it can safely reduce pain caused by nerve damage from diabetes. It will involve about 300 adults who have had this type of pain in their feet or legs for at least a year. Researchers will compare different doses of th…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated Mar 27, 2026 12:41 UTC
-
New drug trial offers hope for millions suffering diabetic foot pain
Symptom relief Recruiting nowThis study is testing if an investigational drug called Suzetrigine can safely reduce pain caused by nerve damage from diabetes. About 734 adults with long-term diabetic foot and leg pain will receive either the drug or a placebo for 12 weeks. The main goal is to see if Suzetrigi…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC
-
Major trial tests new hope for millions suffering diabetic nerve pain
Symptom relief Recruiting nowThis study aims to see if a new drug called Suzetrigine can safely reduce pain in people with diabetic peripheral neuropathy, a common and painful nerve condition. It will involve about 1100 adults with type 1 or type 2 diabetes who have significant daily pain in their feet or le…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated Mar 05, 2026 13:59 UTC